C22H27N3O, monoclinic, P21/c (no. 14), a = 18.4984(4) Å, b = 11.4221(3) Å, c = 9.79600(19) Å, β = 90.9652(19)°, V = 2069.51(8) Å3, Z = 4, Rgt(F) = 0.0605, wRref(F2) = 0.1773, T = 293(2) K
C62H80Mn2N16O18, triclinic, P1̅ (no. 2), a = 11.3232(10) Å, b = 12.879(2) Å, c = 13.035(2) Å, α = 84...
C32H41N7NiO8, monoclinic, P21/c (no. 14), a = 10.0076(5) Å, b = 18.6561(10) Å, c = 19.0893(18) Å, β ...
C20H14N2O2, monoclinic, C2/c (no. 15), a = 17.8410(5) Å, b = 15.3081(4) Å, c = 11.3881(3) Å, β = 104...
C32H30N8O5, orthorhombic, P212121 (no. 19), a = 9.1258(4) Å, b = 10.6225(5) Å, c = 30.1870(14) Å, V ...
C26H24N4O5, triclinic, P1̅ (no. 2), a = 8.0382(5) Å, b = 10.0185(6) Å, c = 15.2333(9) Å, α = 81.8...
C17H22N2O3, monoclinic, P21/c, (no. 14) a = 18.419(4) Å, b = 5.7524(12) Å, c = 17.575(4) Å, β = 117....
C13H11N3O2, monoclinic, P2+/n (no. 14), a = 7.6199(9) Å, b = 12.357(2) Å, c = 12.460(1) Å, β = 95.13...
C25H17N2O8, triclinic, P1̄ (no. 2), a = 9.6002(5) Å, b = 10.4192(5) Å, c = 11.0226(5) Å, α = 93.412(...
C18H17N3O3S, monoclinic, P121/c1 (no. 14), a = 15.705(2) Å, b = 12.083(2) Å, c = 9.368(1) Å, β = 102...
C6H9N3O3, monoclinic, P21/n (no. 14), a = 9.5584(4) Å, b = 6.7828(3) Å, c = 12.8337(6) Å, β = 103.88...
C15H17N3O4S, monoclinic, P21/c (no. 14), a = 8.7938(5) Å, b = 10.3071(4) Å, c = 18.0413(7) Å, β = 79...
The title compound, C24H21N3O3, crystallizes with two unique but closely r.m.s. overlay fit = 0.215 ...
C44H54Cd2N4O12, monoclinic, C2/c, a = 22.818(5) Å, b = 10.714(2) Å, c = 19.163(4) Å, β = 102.43(3...
C25H28N6O7Zn, triclinic, P1̄ (no. 2), a = 7.8073(19) Å, b = 11.350(3) Å, c = 15.515(4) Å, α = 95.006...
In the title compound, C25H22N2O3, the central imidazole ring makes dihedral angles of 48.43 (10), 2...
C62H80Mn2N16O18, triclinic, P1̅ (no. 2), a = 11.3232(10) Å, b = 12.879(2) Å, c = 13.035(2) Å, α = 84...
C32H41N7NiO8, monoclinic, P21/c (no. 14), a = 10.0076(5) Å, b = 18.6561(10) Å, c = 19.0893(18) Å, β ...
C20H14N2O2, monoclinic, C2/c (no. 15), a = 17.8410(5) Å, b = 15.3081(4) Å, c = 11.3881(3) Å, β = 104...
C32H30N8O5, orthorhombic, P212121 (no. 19), a = 9.1258(4) Å, b = 10.6225(5) Å, c = 30.1870(14) Å, V ...
C26H24N4O5, triclinic, P1̅ (no. 2), a = 8.0382(5) Å, b = 10.0185(6) Å, c = 15.2333(9) Å, α = 81.8...
C17H22N2O3, monoclinic, P21/c, (no. 14) a = 18.419(4) Å, b = 5.7524(12) Å, c = 17.575(4) Å, β = 117....
C13H11N3O2, monoclinic, P2+/n (no. 14), a = 7.6199(9) Å, b = 12.357(2) Å, c = 12.460(1) Å, β = 95.13...
C25H17N2O8, triclinic, P1̄ (no. 2), a = 9.6002(5) Å, b = 10.4192(5) Å, c = 11.0226(5) Å, α = 93.412(...
C18H17N3O3S, monoclinic, P121/c1 (no. 14), a = 15.705(2) Å, b = 12.083(2) Å, c = 9.368(1) Å, β = 102...
C6H9N3O3, monoclinic, P21/n (no. 14), a = 9.5584(4) Å, b = 6.7828(3) Å, c = 12.8337(6) Å, β = 103.88...
C15H17N3O4S, monoclinic, P21/c (no. 14), a = 8.7938(5) Å, b = 10.3071(4) Å, c = 18.0413(7) Å, β = 79...
The title compound, C24H21N3O3, crystallizes with two unique but closely r.m.s. overlay fit = 0.215 ...
C44H54Cd2N4O12, monoclinic, C2/c, a = 22.818(5) Å, b = 10.714(2) Å, c = 19.163(4) Å, β = 102.43(3...
C25H28N6O7Zn, triclinic, P1̄ (no. 2), a = 7.8073(19) Å, b = 11.350(3) Å, c = 15.515(4) Å, α = 95.006...
In the title compound, C25H22N2O3, the central imidazole ring makes dihedral angles of 48.43 (10), 2...
C62H80Mn2N16O18, triclinic, P1̅ (no. 2), a = 11.3232(10) Å, b = 12.879(2) Å, c = 13.035(2) Å, α = 84...
C32H41N7NiO8, monoclinic, P21/c (no. 14), a = 10.0076(5) Å, b = 18.6561(10) Å, c = 19.0893(18) Å, β ...
C20H14N2O2, monoclinic, C2/c (no. 15), a = 17.8410(5) Å, b = 15.3081(4) Å, c = 11.3881(3) Å, β = 104...
DOI
Add to ORKG